Status:

NOT_YET_RECRUITING

CoCrMo LOCK Bipolar Femoral Heads FU

Lead Sponsor:

Limacorporate S.p.a

Conditions:

Femoral Fractures

Hip Arthropathy

Eligibility:

All Genders

18+ years

Brief Summary

Study design: monocentric, retrospective, observational and post-market clinical study. Purpose: To demonstrate the safety and performance of CoCrMo LOCK bipolar femoral heads. The eligible study pop...

Detailed Description

The study is aiming to demoranstrate safety and performance of LOCK Bipolar femoral heads and will do it by considering the rate of revision of any prosthesis component and dislocation, by x-ray evalu...

Eligibility Criteria

Inclusion

  • Displaced intracapsular hip fracture (Garden III-IV).
  • Subjects underwent a Bipolar Hemiarthroplasty with a CoCrMo LOCK Bipolar femoral head as per their Indication For Use from January 1st, 2023, onwards.
  • No concurrent joint disease at the time of the surgery.
  • Absence of severe cognitive dysfunction demonstrated by 3 or more correct answers on the Pfeiffer test.
  • Ability to ambulate independently with or without walking aids before surgery.
  • Subject willingness to participate.

Exclusion

  • Undisplaced or minimally displaced intracapsular hip fracture (Garden I-II).
  • Any CoCrMo LOCK Bipolar femoral head contraindication for use as reported in the current Instruction For Use.
  • Pathological fracture secondary to malignant disease.
  • Subjects with rheumatoid arthritis or symptomatic osteoarthritis.
  • Previous treatment to the same hip for a fracture at the time of the surgery.
  • Subjects who were deemed unsuitable for the surgical procedures by the anesthesiologist.
  • Severe cognitive dysfunction or cognitive impairment demonstrated by 2 or less correct answers on the Pfeiffer test.
  • Unable to walk before surgery (e.g., wheelchair or bed-ridden subjects).

Key Trial Info

Start Date :

October 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2028

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06885359

Start Date

October 1 2025

End Date

December 1 2028

Last Update

March 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Splošna bolnišnica Celje

Celje, Slovenia, 3000